MSD MAR 10

Gardasil

1. Next Year: A Vaccine for Cervical Cancer - Also for Boys

   Mar 9, 2015 | Ynet

   By Yaron Kelner
   
   
   http://www.ynet.co.il/articles/0,7340,L-4634944,00.html
2. Beginning in the Coming School Year: A Vaccine Against HPV For Boys

   Mar 9, 2015 | Haaretz

   By Ido Efrati
   
   
   http://www.haaretz.co.il/news/health/1.2584607
3. The HPV Vaccine - For Boys in Eigth Grade

   Mar 10, 2015 | Doctors

   http://www.doctors.co.il/ar/18182/%D7%97%D7%99%D7%A1%D7%95%D7%9F+HPV+-+%D7%9C%D7%91%D7%A0%D7%99%D7%9D+%D7%91%D7%9B%D7%99%D7%AA%D7%94+%D7%97

Gardasil

1. Next Year: A Vaccine for Cervical Cancer - Also for Boys

   Mar 9, 2015 | Ynet

   By Yaron Kelner

   Starting next school year, children in the eighth grade will receive the vaccine against human papilloma virus. Currently, the vaccine is given to girls entering the eighth grade at school. HPV vaccine is designed to prevent cervical cancer in girls, but the Ministry of Health makes clear that the virus can also cause various types of cancers among boys.
    
   "We're talking about 200 cases of pharyngeal cancer, rectal cancer, genital cancer and more. The virus also causes warts among one percent of infected patients," explains Prof. Itamar Grotto, head of the Public Health Services at the Ministry of Health.
   
   In addition, vaccinations for boys helps to prevent the virus spreading among girls. In recent years there has been resistance to the vaccine on the grounds that it is given at too early of an age. The vaccine is given early on in order to vaccinate the children before the start being sexual active. Professor Grotto says by applying this into the system as a routine vaccination shows that this is not about gender.
    
   The Health Ministry said that the move "is another step in dealing with the virus, helping to reduce the incidence of the disease among boys and girls. This State of Israel joins other Western countries in providing maximum protection against virus and diseases that result from it."
   
    HPV: 150 sub-species
   
   There are 150 sub-species of human papillomavirus (HPV), 40 of which cause STDs. Some of the varieties cause genital warts, while others can cause anal cancer, cervical cancer and vaginal and penile cancer. Sexually transmitted diseases caused by HPV usually do not cause any symptoms, but untreated cases may degenerate into cancer.
   
   Israel approved two vaccines against the virus. The Gardasil vaccine protects against four types 6, 11, 16 and 18. Strains 6 and 11 cause genital warts; the vaccine provides about 90% protection against these strains, and 70% protection against the other two types.
   
   The other is Cervarix vaccine protects against types 16 and 18, are responsible for 70% of precancerous lesions that can cause cancer, but it does not protect against the formation of genital warts or anal. Both vaccines recommended for girls before the onset of sexual intercourse.

   Return to headline | Return to top

2. Beginning in the Coming School Year: A Vaccine Against HPV For Boys

   Mar 9, 2015 | Haaretz

   By Ido Efrati

   Ministry of Health announced today (Monday) that for the coming academic year there will be a vaccine against human papilloma virus provided also for boys in the eighth grade. Currently, schools provide vaccine "Gardasil" only to girls - it is given to girls entering eighth grade, in three doses, as a prevention against cervical cancer.

   At the same time the Ministry also announced a change in the vaccination regime, from three doses to two doses (for both sexes) in light of updated data in medical literature and in accordance with the registration of the vaccine around the world and in Israel.

   Papillomavirus (HPV - Human Papiloma Virus) is in fact includes 200 types of the virus, most of them are transmitted sexually. Unlike the HIV virus, human papilloma virus is not transmitted through semen or infected blood exposure, but through the skin and therefore protected sex does not necessarily prevent infection. In most cases, carriers do not  develop symptoms and immune system can overcome the virus a period of up to two years. Yet in cases where the carrier shows key symptoms, small growths on the skin called "condyloma". These tumors are very common and most of them can be treated medically with liquid nitrogen, cautery, laser or medicinal ointment. A small minority of cases can result in cancer in the cervix, vagina, anus, penis and colon.

   According to the Israel Center for HPV condyloma virus, HPV is the most common sexual disease in the western world. Circulation so great that US studies have shown that at any given moment 26.8% of people aged 14-59 are carriers of the virus. According to the study, at age 50, 80% of Americans have at least one strain of virus.

   In 2012 the American Association of Pediatrics issued a recommendation to vaccinate children not only girls but also boys from the age of 11. Doctors Association believes that vaccination will reduce the rate of white adhesive between partners in the future, as well as the percentage of tumors that develop following the infection. "The State of Israel is joining the first line of the Western countries who are providing the maximum protection against virus and diseases," say the Ministry of Health.

   In 2014, the HPV vaccine was put into the health basket for men and boys aged 9-26, protecting against four strains of the virus. The decision was made following numerous cases were reported of penile and rectal cancer in men who were having same sex relations. A year earlier, the Knesset had approved HPV vaccine for all girls in the eighth grade.

   Return to headline | Return to top

3. The HPV Vaccine - For Boys in Eigth Grade

   Mar 10, 2015 | Doctors

   In the beginning of the coming school year, the Ministry of Health will begin administering the vaccination against the human papilloma virus in boys in the eighth grade, in addition to vaccinating girls, according to the notice released by the Ministry of Health today (Monday).
   

   
   School children up to age 14 who will be vaccinated, will be given the vaccine "Gardasil," which has changed slightly from three doses to two doses, following updated data that was provided in medical literature and in accordance with the registration of the vaccine around the world and in Israel. In the other cases, those who are vaccinated after the age of 14, the guidelines will not change and patients will continue to receive three doses. The Health Ministry hopes that this move is another step in dealing with the virus and should help reduce the incidence among boys and among girls.
   
   In Israel, 5,000 women developed pre-cancerous conditions and 200 new patients are diagnosed with cervical cancer each year. The vaccine is designed to protect girls before they are sexually active, and now boys will also be vaccinated.
   

   Return to headline | Return to top